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Birbeck granules (BG) are organelles speciﬁc to Langerhans cells (LCs), which form where the C-type lectin
Langerin accumulates. Their function remains obscure due to morphologic and dynamic alterations induced by
maturation of isolated LC. In this study, we attempted to reconstitute Langerin trafﬁc and BG formation in the
endosomal pathway of a human melanoma cell line. In the selected Langerin-transfected cell line, M10-22E,
Langerin is distributed between the early recycling endosomal compartment and the plasma membrane, as in LC.
Whereas mainly concentrated in membranes related to the Rab11þ endosomal recycling compartment at the steady
state, Langerin also recycles in M10-22E cells and drives BG biogenesis in the endosomal recycling compartment.
Interruption of endocytosis or recycling induces redistribution of intracellular Langerin with an associated
alteration in BG location and morphology. We have, therefore, generated a stable, Langerin-transfected cell line in
which Langerin trafﬁc and distribution and BG morphology replicate that seen in freshly isolated LC. This practical
model can now be used to further delineate the nature and function of BG.
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Birbeck granule (BG) (Birbeck et al, 1961) and Langerhans
cells (LC) (Wolff, 1991) have puzzled dermatologists and cell
biologists for decades. The recent identification of Langerin,
a C-type lectin possessing the ability to induce pentalami-
nar structures resembling BG in fibroblasts, has shed light
on the biogenesis of BGs (Valladeau et al, 2000). A
relationship between BG and Langerin was subsequently
demonstrated in freshly isolated human LC (McDermott
et al, 2002), however, the function of BG and their role in
intracellular traffic in LC remain largely unknown. The most
compelling reason behind this lack of understanding is the
difficulty involved in studying intracellular traffic in this cell
population. Epidermal LC are exceptionally challenging to
maintain in the immature state in vitro. Within hours, they
commence a maturation process, which induces profound
changes in their morphology, immunophenotype and func-
tion. Not surprisingly, given their dynamic nature, maturation
also affects the number, morphology and distribution of BG
(Romani et al, 1989; Sto¨ssel et al, 1990; Teunissen et al,
1990). As a consequence, using existing methods it has
hitherto not been possible to satisfactorily study the role of
BG, in particular, the molecular mechanisms underlying
their segregation within the endosomal recycling compart-
ment (ERC) (McDermott et al, 2002). and their function in
intracellular traffic. Such studies will only become feasible
when a method to maintain highly enriched epidermal LC in
the immature state in vitro is developed. As an alternative,
we elected to generate a Langerin-transfected cell line
model, which stably reproduces the expression and traffic
of Langerin and the distribution of BG, comparable to that
observed in LC.
Results
Langerin distribution in transfected M10 cells closely
resembles freshly isolated LC Langerin-transfected M10
clones were derived and screened using the following
criteria: (1) homogeneity in Langerin expression, (2) low cell
surface Langerin expression and (3) intracellular localization
of Langerin showing accumulation in the ERC, as in LC.
Figure 1B shows Langerin staining in the selected Langerin-
transfected clone 22E (M10-22E), as compared to freshly
isolated LC (Fig 1A). Given that M10 cells are adherent and
significantly larger than LC, as assessed by the combination
of fluorescence microscopy (Fig 1B) and FACS analysis (Fig
1D), clone 22E cells express a homogeneous amount of
Langerin, with relatively low cell surface expression, similar
to freshly isolated LC (Fig 1A, C).
Langerin is an endocytic marker in LC (McDermott et al,
2002), located in early endosomal structures, predominantly
on recycling endosomal membranes and, to a lesser
degree, in sorting endosomes. As in LC, multiple labelling
immunofluorescence analysis performed on M10-22E cells
showed low-level co-localization of Langerin with EEA1, a1The first two authors contributed equally to the work.
Abbreviations: BG, Birbeck granule; ERC, endosomal recycling
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marker of sorting endosomal membranes (Fig 1E). Sig-
nificantly, and again coherent with LC, the majority of
Langerin co-localized with Rab11, a marker of recycling
endosomal membranes (Fig 1F). In contrast, no specific
concentration of Langerin was detected in the Golgi
apparatus (not shown) or in late endosomes and lysosomes
(CD63, Fig 1G). As compared to LC, M10 cells express high
levels of TfR (CD71), a protein which cycles continuously
between the plasma membrane and early endosomal
compartments (Hopkins, 1983). At the steady state, TfR
provides a reference marker for all early endosomal
membranes and a clear co-localization between Langerin
and TfR is observed (Fig 1H). Therefore, in the selected
M10-22E cells, Langerin is distributed between the early
recycling endosomal compartment and the plasma mem-
brane, with accumulation in the Rab11þ ERC and a low
surface to internal Langerin ratio, as in LC.
Langerin recycles in M10-22E cells and drives Birbeck
granule biogenesis in the ERC Incubation of M10-22E
cells, at 41C, in the presence of the anti-Langerin mAb
DCGM4, labelled only the cell surface (Fig 2A), whereas at
19.51C, it reached peripheral vesicular compartments
identified as EEA1þ early/sorting endosomes (Fig 2B). In
contrast, incubation at 371C allowed DCGM4 to attain, and
concentrate in, the Rab11þ ERC (Fig 2C). Ultrastructural
examination of M10-22E cells revealed the presence of BG,
structures not seen in control non-transfected M10 cells.
These BG were essentially located in the pericentriolar
region (Fig 2D) and only rarely appended to the plasma
membrane. They appeared often in continuity with, or in
close vicinity to, other endosomal structures. These results
show that although mainly concentrated in membranes
related to the Rab11þ ERC at the steady state, Langerin is
an endocytic protein in M10-22E cells. They also confirm
that Langerin can induce the biogenesis of BG. Together,
they suggest that in M10-22E cells, as in LC, Langerin is a
recycling molecule, which is dynamically retained in the
endosomal pathway and which drives BG formation.
Interruption of endocytosis or recycling induces redis-
tribution of intracellular Langerin Cytochalasin D and
latrunculin A, through an effect on F-actin filaments, block
the initial steps of Langerin endocytosis without affecting
the recycling pathway in freshly isolated LC (McDermott
et al, 2002). Both drugs were effective in blocking the inter-
nalization of the mAb DCGM4, bound to Langerin at the
surface of M10-22E cells (not shown). Consistent with
previous observations in LC (McDermott et al, 2002), treat-
ment with these drugs was accompanied by a redistribution
of the internal Langerin pool to the cell periphery, as
demonstrated by confocal microscopy (Fig 3C) and con-
firmed by FACS analysis revealing an increase in Langerin
cell surface expression (Fig 3A). As in LC, electron
microscopy showed numerous coated pits labelled by the
gold-conjugated anti-Langerin mAb and many open-ended
BG-like structures (Hanau et al , 1988) appended to the
plasma membrane and coated either throughout their entire
length (Fig 3F, G) or at their distal end (Fig 3H). Notably, the
distribution of Rab11 was not profoundly affected by this
treatment (Fig 3C), confirming the specific effect of these
drugs on the endocytic process of cargo molecules.
Brefeldin A (BFA) partially inhibits recycling of internalized
Langerin in LC (McDermott et al, 2002), leading to
accumulation of Langerin in Rab11þ structures and a
Figure 1
Localization of Langerin in Langerinþ M10-22E cells. Langerin
localization was compared in freshly isolated Langerhans cells (A) and
in the Langerinþ M10-22E cell line (B). Cells were labelled with the anti-
Langerin mAb DCGM4, followed by an FITC-conjugated donkey anti-
mouse antibody. The intensity of cell surface Langerin expression was
also examined in both freshly isolated LC (C) and M10-22E cells (D) by
flow cytometry. In these experiments, cells were labelled with the anti-
Langerin mAb DCGM4, followed by an FITC-conjugated sheep anti-
mouse antibody. To define the exact localization of Langerin in M10-
22E cells, cells were incubated simultaneously with a goat anti-EEA1
antibody (E), a rabbit anti-Rab11 (F), and a mouse anti-Langerin
(DCGM4) (E, F), before secondary staining with anti-goat FITC, anti-
rabbit Cy5 and anti-mouse TRITC. In (G) and (H), the cells were
incubated with anti-Langerin rabbit antiserum, secondarily labelled with
anti-Rabbit-FITC before further incubation with the directly coupled
antibodies CD63-Cy3 (G) or an anti-CD71/TfR mAb revealed by a
TRITC-conjugated donkey anti-mouse (H). Inserts represent zoomed
area from the perinuclear region. (E) and (F) are at the same
magnification. Scale bars¼10 mm.
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concomitant depletion from the plasma membrane.
Through an effect on coat formation, BFA has also been
shown to induce fusion and redistribution of membranes of
the early endocytic pathway and trans-Golgi network (TGN),
resulting in the formation of a continuous tubular network in
some cell types (Lippincott-Schwartz et al, 1991; Wood
et al, 1991). When M10-22E cells were incubated with BFA,
FACS analysis revealed a decrease in cell surface Langerin
expression (Fig 3B), whereas morphologically, elongated
structures positive for both Langerin and Rab11 staining
became apparent (Fig 3D). Electron microscopic studies
showed that these structures were associated with a
tubular and vacuolar HRPþ network, involving numerous,
often elongated BG (Fig 3I–L). As expected, TfR distribution
was similarly affected and coincidence with Rab11 staining
was reinforced (Fig 3E). Together, these studies demon-
strate the proximity of the relationship between Langerin
traffic and BG biogenesis in our cell model, as in the
physiological state.
Discussion
In their landmark paper on Langerin, Valladeau et al (2000)
showed that expression of Langerin is sufficient to drive
formation of BG in recipient cells. This transfection,
however, also led to the non-physiological generation of
pentalaminar structures in membranes unrelated to the
endosomal pathway (Valladeau et al, 2000). This contrasts
with the classical pericentriolar distribution of BG in freshly
isolated LC and suggests that these transfected cells might
not be an appropriate model in which to further investigate
the cellular biology of BG. Moreover, the dynamics of the
structures generated in the early recycling compartment
Figure2
Internalization of the anti-Langerin
mAb DCGM4 and ultrastructural char-
acteristics of the M10-22E cells. Cells
were incubated with the mouse anti-
Langerin mAb DCGM4 for 1 h at either
41C (A), 19.51C (B), or 371C (C). After
fixation and permeabilization, cells were
incubated with either donkey anti-mouse
TRITC (A and B) or donkey anti-mouse
FITC (C) before counter staining with
rabbit anti-Rab11 followed by donkey
anti-rabbit FITC (A) or donkey anti-rabbit
TRITC (C), or with anti-EEA1 followed by
donkey anti-goat FITC (B). (A), (B) and (C)
are at the same magnification. Scale
bar¼ 10 mm. Under the electron micro-
scope (D) Langerinþ M10-22E cells con-
tain, in the pericentriolar area, numerous
BG (arrows). Their central striation is
clearly seen in the inferior left quadrant
of (D). C, centriole; NU, nucleus. Scale
bars¼ 0.5 mm.
Figure 3
Effect of drugs on the distribution of Langerin and Birbeck granules in M10-22E cells. (A, B) Cells were incubated in the absence of drugs (Ctrl)
or in the presence of either cytochalasin D (Cyto D) or Brefeldin A (BFA) for 60 min at 371C. Langerin surface expression was then measured by FACS
scan. Similar results were obtained in five independent experiments. MFI, mean fluorescence intensity. (C–E) M10-22E cells were incubated with
either cytochalasin D (C) or BFA (D, E), for 60 min at 371C. Cells were then stained simultaneously with a rabbit anti-Rab11 antibody and either a
mouse anti-Langerin (C, D) or a mouse anti-TfR (E) mAb, before labelling with anti-rabbit FITC and anti-mouse TRITC. Scale bars¼ 10 mm. (F–H)
Cells were incubated for 30 min at 371C with cytochalasin D (10 mg per mL), before addition of gold-labelled anti-Langerin mAb for a further 15 min,
still in the presence of cytochalasin D. As shown in the inset (F) gold particles accumulate in coated pits. ‘‘BG-like structures’’, coated either
throughout their entire length (F, G, arrowheads) or at their distal end (H, arrowheads), are also present. Note, in the upper left-hand portion of (G), the
presence of a coat (arrowheads) along an ‘‘open-ended BG-like structure’’. (I–L) Cells were incubated for 30 min at 371C with BFA (10 mg per mL),
before addition of HRP (10 mg per mL) for a further 30 min, still in the presence of BFA. Two elongated BG HRPþ (arrows), connected to a vacuolar
HRPþ endosomal structure (star), are visible in (I) and (J), whereas in (K) and (L) two HRPþ BG (arrows) are seen, one of which is connected to a
tubular HRPþ network. In images (I) and (J), as well as in (K) and (L), a single region is viewed from different angles (I, tilt þ121; J, tilt 121 and K, tilt
þ 161; L, tilt þ321). (G) and (H) are at the same magnification. Scale bars¼ 0.5 mm.
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was not investigated. The aim of this study was, therefore,
to establish a stable, Langerin-transfected, cell line, which
displays properties similar to those of freshly isolated LC in
terms of the distribution and traffic of Langerin as well as
BG biogenesis within the early endosomal pathway. Herein,
we describe a transfected melanoma cell line, M10-22E,
which possesses organelles displaying all the attributes of
BG in freshly isolated LC. Moreover, in all parameters
studied, the localization and the traffic of Langerin closely
resemble those seen in the physiological state.
Expression of Langerin in clone M10-22E is homoge-
neous, with little cell surface expression and accumulation
in the ERC, reflecting exactly the pattern of Langerin
distribution observed in freshly isolated LC. In our model,
Langerin is a recycling-endocytic protein dynamically
retained on the membranes of the ERC, again as in LC
(McDermott et al, 2002). Moreover, Langerin expression in
the M10 cell line induces the formation of BG located mainly
in the pericentriolar region, whereas interference with
endocytosis or recycling demonstrates that these BG are
dynamic structures, as in freshly isolated LC (McDermott
et al, 2002).
LC can be isolated from human skin, however, the
absolute numbers are limited and these cells tend to
undergo a spontaneous maturation process (Romani et al,
1989; Sto¨ssel et al, 1990; Teunissen et al, 1990). LC like
cells expressing the BG marker Lag/CD207 (Valladeau et al,
2000) have also been generated from monocytes (Geiss-
mann et al, 1998), with a yield of approximately 30% of the
final cell number, and from CD34þ cells (Strobl et al, 1996,
1997), with a LC yield of approximately 19%–21% final cell
number. Although such cells express Langerin, its distribu-
tion and traffic have not been elucidated and, as is evident,
representative cells constitute only a small proportion of all
cells generated. The inherent value of our model is that it
should allow us to generate large numbers of uniform,
Langerin expressing, BG containing cells, which behave like
immature LC in terms of Langerin traffic and distribution and
BG formation. This will allow biochemical studies of
Langerin and further investigation of the mechanisms which
underly the association of Langerin and BG with the ERC. It
could also potentially allow us to isolate BG and determine
their component molecules.
In conclusion, we have generated a stable, Langerin-
transfected human melanoma cell line, in which Langerin
traffic, distribution and kinetics and BG morphology,
distribution and dynamics closely resemble those observed
in freshly isolated LC. We believe that this will prove an
important tool with which to study unresolved questions
relevant to the molecular components and function of BG.
Materials and Methods
Expression of Langerin in M10 Cells LC were isolated from skin
samples of patients undergoing plastic surgery. Total RNA was
extracted and Langerin cDNA obtained by RT-PCR. The sequence
of the cDNA clone was verified using the BigDye terminator
sequencing kit (Perkin-Elmer France, Les Ullis, France) and was
identical to sequence AJ242859 in Genbank. The cDNA was then
cloned into the pEGFP-N3 expression vector (Clontech, Palo Alto,
California). The human M10 melanoma cell line, kindly provided by
Dr Thierry Hercend (Villejuif, France) and maintained in RPMI 1640
culture medium, was then transfected with the Langerin expression
vector using Fugen transfection reagent (Roche Diagnostics,
Meylan, France). Stable clones were selected using G418 (500
mg per mL) (Invitrogen, Cergy-Pontoise, France) and screened for
Langerin expression by immunofluorescence studies on fixed
permeabilized cells and by FACS analysis.
Antibodies and reagents Mouse mAbs were as follows: DCGM4
(IgG1, recognizing an extracellular epitope of Langerin, Beckman-
Coulter, Villepinte, France), H5C6 (IgG1, anti-CD63, kindly provided
by Dr Franc¸ois Lanza, EFS-Alsace, Strasbourg) and DF 1513 (IgG1,
anti-CD71/transferrin receptor (TfR), Sigma-Aldrich, Saint Quentin
Fallavier, France). A goat anti-EEA1 mAb (N-19) was obtained from
Santa Cruz Biotechnology (Santa Cruz, California). Polyclonal
rabbit Abs were raised against (i) full length recombinant Rab11
expressed in Escherichia coli and affinity purified as previously
described (Martinez et al, 1994) and (ii) the peptide sequence Tyr–
Met–Val–Glu–Lys–Glu–Ala–Pro–Asp–Ala–His–Phe–Thr–Val–Asp–
Lys–Gln corresponding to part of the Langerin cytoplasmic tail
(Neosystem, Strasbourg, France and Eurogentec, Herstal, Bel-
gium). H5C6 was directly coupled to Cyanin 3 according to the
manufacturer’s instructions (Amersham-Biosciences, Les Ullis,
France). FITC-conjugated mouse IgG1 (Pharmingen, Becton
Dickinson, Le Pont de Claix, France) was employed as an isotype
control in cytometric analyses. An FITC-conjugated, affinity-
isolated F(ab0)2 fraction of a sheep anti-mouse Ig antibody
(Silenius, Hawthorn, Victoria, Australia) was used for indirect
immunofluorescence labelling procedures in FACS analyses.
TRITC or FITC-conjugated donkey anti-mouse, -rabbit or -goat
IgG F(ab0)2 fragments (Jackson ImmunoResearch, West Grove,
Pennsylvania) were employed for indirect immunofluorescence
staining procedures in confocal microscopy. DCGM4 was gold
labelled as previously described (McDermott et al, 2002).
Latrunculin A was provided by Molecular Probes (Eugene,
Oregon). Cytochalasin D, horseradish peroxidase (HRP) type II and
brefeldin A (BFA) were from Sigma Chemical.
Flow cytometry Langerin-transfected M10 cells were incubated
with either the anti-Langerin mAb DCGM4 or the anti-TfR mAb DF
1513 (30 min at 41C), then with FITC-conjugated F(ab0)2 fraction of
a sheep anti-mouse Ig Ab (30 min at 41C). After fixation, cells were
analyzed with a FACScan cytometer (Becton Dickinson Bios-
ciences, San Jose, California). IgG1 isotype controls were stained
and examined simultaneously. In other experiments, M10-22E cells
were incubated for 60 min at 371C in the presence of either BFA (10
mg per mL), cytochalasin D (10 mg per mL) or latrunculin A (12.5 mg
per mL), then cooled to 41C before labelling and analysis.
Immunoﬂuorescence staining and confocal microscopy Im-
munofluorescence microscopy of fixed permeabilized cells was
carried out as previously described (McDermott et al, 2002) using a
Leica SP2 confocal microscope (Leica Microsystems, Heidelberg,
Germany).
Internalization of mAbs Langerin transfected M10 cells were
incubated with DCGM4 in RPMI 1640 (2 mg per mL) for 60 min at
41C. Cells were then chased or not at 19.51C or 371C before
fixation and permeabilization. They were then processed for
multiple labelling as previously described (McDermott et al, 2002).
Immunoelectron microscopy Langerin-transfected M10 cells
were either fixed immediately, at 371C, or pre-incubated for 30
min at 371C with cytochalasin D (10 mg per mL), then incubated
with gold-labelled anti-Langerin mAb (final dilution 1:100) for 15 or
30 min, still in the presence of cytochalasin D, and only then fixed.
Fixation was performed as previously described (McDermott et al,
2002). Ultrathin sections were examined under a Philips CM 120
BioTwin electron microscope (Eindhoven, The Netherlands) (120 kV).
In a second series of experiments, M10-22E cells were
incubated at 371C for 30 min with BFA (10 mg per mL) and then
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for 30 min in the presence of both BFA (10 mg per mL) and HRP (10
mg per mL). The cells were subsequently processed according to
Tooze and Hollinshead (1991) and Griffiths et al (1989), as
previously described (McDermott et al, 2002).
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